相关实验视频
Updated: Jan 18, 2026

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.7K
抗脂抗体持久的阳性与血液透析患者内皮功能障碍恶化有关:一个跨部分研究
Maxime Taghavi1,2, Saleh Kaysi1,2, Lila Bekkai1
1Nephrology and Dialysis Department, Brugmann University Hospital, Université Libre de Bruxelles (ULB), 1020 Brussels, Belgium.
Journal of clinical medicine
|September 13, 2025
概括
血液透析 (HD) 患者的持续抗脂抗体 (aPL) 阳性与更严重的内皮功能障碍有关. 流媒扩张 (FMD) 测量显示,在患有HD的aPL阳性个体中,血管功能显著降低.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血管生物学 血管生物学
- 免疫学 免疫学 免疫学
背景情况:
- 内皮功能障碍在需要血液透析 (HD) 的末期病患者中很普遍.
- 抗脂抗体 (aPL) 阳性是某些HD患者的一种持久性疾病.
- 在HD患者中,aPL阳性和内皮功能障碍严重程度之间的关联尚未得到充分证实.
研究的目的:
- 调查持续抗脂抗体 (aPL) 阳性是否与血液透析 (HD) 患者更严重的内皮功能障碍有关.
- 与对照人群相比,在aPL阳性HD患者中使用流媒扩张 (FMD) 评估内皮功能.
主要方法:
- 对血液透析 (HD) 患者进行了一项横截面研究.
- 在17名aPL阳性患者和17名匹配对照中测量了手臂动脉的流媒体扩张 (FMD).
- 匹配标准包括年龄,性别,糖尿病,吸烟状态和透析充分性 (Kt/V).
主要成果:
- 与对照组 (11.8%) (p = 0.006) 相比,aPL阳性组 (6.9%) 的口病明显较低.
- aPL阳性与更高的c-反应蛋白水平和更长的HD年产相关.
- 两组之间在透析前尿素,尿液输出,透析充分性 (Kt/V) 或心血管病史方面没有发现显著差异.
结论:
- 在血液透析 (HD) 患者中,持久的抗脂抗体 (aPL) 阳性与更严重的内皮功能障碍有关,正如减少的口疾病所示.
- 这些发现表明aPL状态和HD患者的血管健康之间存在联系.
- 需要进行更大规模的研究来证实这些结果.
相关概念视频
Peripheral Artery Disease I: Introduction
314
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
314
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
557
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
557
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364
Chronic Kidney Disease II: Clinical Manifestations
557
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557
Peritoneal Dialysis III: Nursing Management
676
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
676
Hemodialysis II: Procedure and Complications
651
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
651

